Cantor Fitzgerald Starts Codexis (CDXS) at Buy; Enabling Pharma/Fuels Enzymes
Tweet Send to a Friend
Cantor Fitzgerald initiates coverage on Codexis, Inc. (Nasdaq: CDXS) with a Buy rating. PT $13.
The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


